title: Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
abstract: Recent data suggest that women obtain greater benefit than men from IV fibrinolysis for acute ischemic stroke. It is unknown whether this gender-thrombolysis advantage extends to those treated with intra-arterial (IA) thrombolysis. The authors evaluated the independent effect of gender among ischemic stroke patients treated with IA fibrinolysis and found no differences in short-term clinical and angiographic outcomes between men and women who received IA thrombolysis for acute ischemic stroke.
authors.affiliation: Department of Neurology, UCLA Medical Center, USA. SHShah@mednet.ucla.edu
authors.forename: S H
authors.initials: SH
authors.lastname: Shah
authors.forename: D S
authors.initials: DS
authors.lastname: Liebeskind
authors.forename: J L
authors.initials: JL
authors.lastname: Saver
authors.forename: S
authors.initials: S
authors.lastname: Starkman
authors.forename: F
authors.initials: F
authors.lastname: Vinuela
authors.forename: G
authors.initials: G
authors.lastname: Duckwiler
authors.forename: R
authors.initials: R
authors.lastname: Jahan
authors.forename: D
authors.initials: D
authors.lastname: Kim
authors.forename: N
authors.initials: N
authors.lastname: Sanossian
authors.forename: P
authors.initials: P
authors.lastname: Vespa
authors.forename: B
authors.initials: B
authors.lastname: Ovbiagele
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy* / Q000453:epidemiology*; D015897:Comorbidity; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods*; D011379:Prognosis; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator